Figure 4
From: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3

TSN inhibits osteosarcoma cells invasion and reserves EMT phenotype. (a) 143B and MG63.2 cells were seeded into the upper chamber of the transwell inserts. After 12 h incubation, images were obtained, Scale bar, 40 μm. Cell invasion was quantified manually. The bars indicate the mean±s.d. Statistically significant differences (Student’s t-test), *P<0.05; **P<0.01; ***P<0.001. (b) 143B cells were seeded on FITC-conjugated gelatin (green) for 12 h. Phalloidin (red) was used to indicate F-actin and nuclei was stained with DAPI (blue). Gelatin degradation areas were the black areas underneath the cells, Scale bar, 10 μm. The bars indicate the mean±s.d. Statistically significant differences (Student’s t-test), ***P<0.001. (c) 3D culture assay. 143B cells were plated onto a layer of Matrigel. DMEM plus 10% Matrigel as well as indicated concentrations of TSN was then added. The on-top mixture was changed every other day. Four days later, cells were photographed, Scale bar, 40 μm. (d) After treatment with TSN for 72 h, a western blot assay was performed. (e) After treatment with TSN for 72 h, the level of N-cadherin (green) and E-cadherin (green) were detected by IF staining. Nuclei were stained with DAPI (blue). Scale bar, 10 μm.